Trial updateRetina
Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START
Completed. Phase 4. Registered enrolment: 50. University Hospital, Bordeaux
Why it matters
Track this study through NCT02246829. No results are posted in this registry record.
The study at a glance
- Registry status
- Completed
- Phase
- Phase 4
- Registered enrolment
- 50
- Results posted
- No
- Sponsor
- University Hospital, Bordeaux
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.